← Back to Clinical Trials
Recruiting NCT06782165

NCT06782165 Long-term Follow up of TMJ Surgery and Evaluation of the 6-month Control as a Prognostic Marker.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06782165
Status Recruiting
Phase
Sponsor Karolinska Institutet
Condition Temporomandibular Disorders (TMD)
Study Type OBSERVATIONAL
Enrollment 91 participants
Start Date 2025-04-01
Primary Completion 2026-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Arthroscopy & saline irrigation aloneDiscectomy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 91 participants in total. It began in 2025-04-01 with a primary completion date of 2026-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to evaluate the long-term outcome of surgical intervention (arthroscopy or discectomy) due to the diagnoses temporomandibular joint disc displacement with or without displacement. The main questions it aims to answer are: * Does the surgical outcome recorded at the earlier 6-month follow up persist at the long-term follow up approximately 10 years postoperatively? * How does the radiologically determined degree of joint degeneration change with time in patients that have had joint surgery? Researchers will compare the six-month surgical outcome to the ten-year outcome to see if temporomandibular joint surgery results are stable over time. Participants with an earlier performed joint surgery will: * Have a clinical examination approximately ten years postoperatively. * Have a temporomandibular joint x-ray scan performed (cone-beam computed tomography).

Eligibility Criteria

Inclusion Criteria: * Patients participating in the studies with ethical approval numbers EPN 2014/764-31/2 and 2014/622-31/1. * Initial diagnosis DDwR or DDwoR. Exclusion Criteria: * Patient unable to verify informed consent.

Contact & Investigator

Central Contact

Mattias Ulmner, DDS, PhD

✉ mattias.ulmner@ki.se

📞 +46 707648141

Principal Investigator

Mattias Ulmner, DDS, PhD

PRINCIPAL INVESTIGATOR

Karolinska Institutet, Department of Dental Medicine

Frequently Asked Questions

Who can join the NCT06782165 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Temporomandibular Disorders (TMD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06782165 currently recruiting?

Yes, NCT06782165 is actively recruiting participants. Contact the research team at mattias.ulmner@ki.se for enrollment information.

Where is the NCT06782165 trial being conducted?

This trial is being conducted at Huddinge, Sweden.

Who is sponsoring the NCT06782165 clinical trial?

NCT06782165 is sponsored by Karolinska Institutet. The principal investigator is Mattias Ulmner, DDS, PhD at Karolinska Institutet, Department of Dental Medicine. The trial plans to enroll 91 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology